{
      "ptx_code": "PTX201",
      "chem_name": "Tenofovir",
      "casrn": "147127-20-6",
      "dtxsid": "DTXSID9040132",
      "smiles": "SGOIRFVFHAKUTI-ZCFIWIBFSA-N",
      "inchikey": "CC(CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O",
      "label": "PTX201 | Tenofovir",
      "pubchem_cid": "21146529",
      "drugbank_id": "DB14126",
      "use_class": "Pharmaceutical",
      "tox_class": "Nephrotoxicity",
      "formula": "C9H14N5O4P",
      "chem_name_user": "Tenofovir",
      "mw_g_mol": "287.22",
      "solubility_h2o_mol_liter": "0.16",
      "source_solubility_h2o": "COMPTOX (OPERA)",
      "henry_coefficient_atm_m3_mol": "1.13e-10",
      "source_henry": "COMPTOX",
      "log_kaw_kh_rt": "8.33",
      "source_kaw": "LSER",
      "pka_acid": "1.7; 2.69",
      "pka_base": "4.00",
      "source_pka": "UFZ; Sirius T3; ACD pKa/GALAS",
      "log_kow_liter_liter": "-1.35",
      "source_kow": "",
      "log_dlipw_ph74_liter_liter": "-2.24",
      "source_dlipw": "Kow QSAR (\u2206mw = 1)",
      "freely_dissolved_fraction": "0.94",
      "density_kg_liter": "1.75",
      "source_density": "COMPTOX",
      "boiling_point": "",
      "source_boiling_point": "",
      "melting_point": "278.00",
      "source_melting_point": "CompTox (Jean-Claude Bradley Open Melting Point Dataset)",
      "vapor_pressure": "",
      "source_vapor_pressure": "",
      "baseline_drerio": "1621810.10",
      "baseline_dmagna": "218776.16",
      "baseline_celegans": "457088.19",
      "baseline_xlaevis": "31067.05",
      "baseline_dmelanogaster": "2022087.76",
      "baseline_cells": "0.28",
      "baseline_cells_generic_micromole_liter_free_ec10": "0.26",
      "moa_drugbank": "Once tenofovir is activated by a bi-phosphorylation it acts as an antiviral acyclic nucleoside phosphonate. It is a potent inhibitor of the viral reverse transcriptase with an inhibitory constant of approximately 0.022 micromolar.[A18473] \n\nOnce activated, tenofovir acts with different mechanisms including the inhibition of viral polymerase causing chain termination and the inhibition of viral synthesis.[L6241] All these activities are attained by its competition with deoxyadenosine 5'-triphosphate in the generation of new viral DNA. Once tenofovir is incorporated in the chain, it induces a chain termination which in order inhibits viral replication.[A178330] The safety of tenofovir relies on its low affinity towards the cellular DNA polymerase including the mitochondrial DNA polymerase gamma.[T324]",
      "protein_binding": "Tenofovir is minimally bound to plasma proteins and only about 7.2% of the administered dose is found in the bound state.[A16539]",
      "moa_t3db": "",
      "aop": [],
      "targets": []
}